Xuejun Xiao | Bioinformatics | Best Researcher Award

Published on by Technology Scientists

Best Researcher Award

                    Xuejun Xiao
Affiliation Xinjiang Medical University
Country China
Scopus ID 56640335200
Documents 8
Citations 132
h-index 4
Subject Area Bioinformatics
Event Technology Scientists Awards

Xuejun Xiao, Xinjiang Medical University

Xuejun Xiao is affiliated with Xinjiang Medical University, China, and has contributed to bioinformatics and biomedical research through scholarly publications indexed in Scopus. The researcher has authored eight indexed publications, received more than one hundred citations, and demonstrated continued academic engagement in cancer biology, immunology, and nanomedicine research. [1]

Abstract

Xuejun Xiao has contributed to interdisciplinary bioinformatics research with emphasis on cancer biology, immune regulation, molecular therapeutics, and nanoparticle-assisted drug delivery. Published studies investigate immune checkpoint modulation, mechanisms of chemotherapy resistance, and advanced biomedical technologies supporting precision medicine. The available scholarly record demonstrates sustained scientific productivity and measurable citation impact within indexed literature. These achievements indicate meaningful participation in translational biomedical research while supporting future innovation in computational biology, oncology, and therapeutic development through collaborative scientific investigation and evidence-based methodologies. [1] [2] [3]

Keywords

Bioinformatics, Cancer Research, Nanoparticles, Drug Delivery, Gastric Cancer, LUAD, Immunotherapy, Siglec-15, Precision Medicine, Computational Biology.

Introduction

Bioinformatics integrates computational methods with biomedical sciences to improve disease understanding and therapeutic discovery. Xuejun Xiao’s scholarly activities align with this interdisciplinary approach by examining molecular mechanisms associated with cancer progression, immune regulation, and targeted treatment strategies through evidence-based experimental investigations. [1]

Research Profile

The research profile demonstrates experience in oncology, molecular biology, and translational medicine. Indexed publications, citation performance, and collaborative scientific outputs illustrate continued participation in biomedical research focused on identifying clinically relevant biomarkers and innovative therapeutic approaches supporting improved patient outcomes. [2]

Research Contributions

Research contributions include investigations into nanoparticle-mediated antibody delivery, immune checkpoint inhibition, macrophage polarization, and mechanisms responsible for chemotherapy resistance. These studies provide valuable scientific knowledge supporting precision oncology and future therapeutic development through multidisciplinary biomedical research collaborations. [1] [3]

Publications

The Scopus record reports eight indexed publications covering bioinformatics, immunology, cancer biology, and targeted therapeutics. These publications have received academic recognition through citations, reflecting their relevance within contemporary biomedical research and contribution to ongoing scientific discussions in related disciplines. [1]

Research Impact

Citation metrics indicate measurable academic influence, with published research supporting continued investigations into molecular oncology and immunotherapy. The combination of citation performance, interdisciplinary collaborations, and translational relevance highlights the significance of the research within biomedical and bioinformatics communities. [2]

Award Suitability

Based on available scholarly indicators, publication quality, citation record, and sustained contributions to bioinformatics and biomedical sciences, Xuejun Xiao demonstrates qualifications consistent with recognition under the Best Researcher Award for advancing scientific knowledge through impactful and collaborative academic research. [1]

Conclusion

Xuejun Xiao’s academic portfolio reflects meaningful contributions to bioinformatics and cancer research through peer-reviewed publications addressing clinically important biomedical challenges. Continued research activity and scholarly collaboration are expected to further support innovation, translational medicine, and evidence-based healthcare advancement. [1]

External Links

References

  1. Xiao, X., et al. (2026). Application of nanoparticles in antibody drug delivery. Frontiers in Bioengineering and Biotechnology.
    https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2026.1759915/full
  2. Xiao, X., et al. (2022). A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating macrophage polarization in the tumor microenvironment. Cancer Letters.
    https://www.sciencedirect.com/science/article/abs/pii/S1043661822002146
  3. Xiao, X., et al. (2020). PLOD2 increases resistance of gastric cancer cells to 5-fluorouracil by upregulating BCRP and inhibiting apoptosis. Cell Biology International.
    https://pubmed.ncbi.nlm.nih.gov/32284742/
  4. Elsevier. (n.d.). Scopus author details: Xuejun Xiao, Author ID 56640335200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56640335200

Béchir Béjaoui | Bioinformatics | Editorial Board Member

Published on by Technology Scientists

Prof. Béchir Béjaoui | Bioinformatics | Editorial Board Member

Researcher | National Institute of Marine Sciences and Technologies | Tunisia

Prof. Béchir Béjaoui is a distinguished marine and environmental scientist affiliated with the National Institute of Marine Sciences and Technologies (INSTM) in Carthage, Tunisia. His research primarily focuses on coastal and marine ecosystem dynamics, climate change impacts, and the application of advanced modeling and machine learning techniques to assess and manage aquatic environments. Over his career, Dr. Béjaoui has authored 34 scientific publications, collectively cited more than 1,130 times across 954 documents, reflecting his strong academic influence and the global relevance of his research. His work integrates remote sensing, numerical modeling, and ecological indicators to evaluate trophic states, water quality, and biodiversity in sensitive environments, such as the Ichkeul Lake Ramsar sanctuary—a UNESCO biosphere reserve and a critical wetland ecosystem in North Africa. Dr. Béjaoui’s studies, including the development of innovative models such as the TRIX-XGBoost Trophic Model and data-driven approaches for forecasting environmental change, provide valuable insights into sustainable wetland management under anthropogenic and climatic pressures. With over 180 international collaborators, his research reflects a strong commitment to multidisciplinary and cross-institutional cooperation, enhancing the global understanding of marine system resilience. His contributions extend beyond academia to inform environmental policy, conservation planning, and adaptive management strategies, bridging the gap between scientific research and socio-environmental decision-making. Through his sustained scholarly output and leadership in marine ecosystem modeling, Dr. Béjaoui continues to play a pivotal role in advancing data-driven sustainability solutions in the Mediterranean and beyond.

Profile: Scopus

Featured Publications

1. Béjaoui, B., … (2025). TRIX-XGBoost Trophic Model for assessing the trophic status of Ichkeul Lake, a Ramsar sanctuary in Northern Tunisia. Marine Pollution Bulletin.

2. Béjaoui, B., … (2025). Remote sensing and numerical modeling to assess the drought in Ichkeul Lake, a RAMSAR wetland and UNESCO biosphere reserve, under climate change. Regional Studies in Marine Science.

3. Béjaoui, B., … (2025, Conference Paper). Machine learning techniques for forecasting the effect of climate change and anthropogenic pressures on coastal wetlands (Ichkeul Lake, Ramsar site).

Prof. Béjaoui’s work drives innovation in environmental modeling, offering scientifically grounded tools to safeguard fragile aquatic ecosystems against climate and human-induced stressors. His research vision promotes sustainable management of marine and wetland resources, contributing to global efforts toward ecological resilience, climate adaptation, and sustainable development.

Mansoureh Azadeh | Bioinformatics | Women Researcher Award

Published on by Technology Scientists

Dr. Mansoureh Azadeh | Bioinformatics | Women Researcher Award

Lab Manager | Zist Fanavari Novin Biotechnology Institute | Iran

Dr. Mansoureh Azadeh is a distinguished molecular and cellular biologist and the Founder and Director of Zist Fanavari Novin Biotechnology Institute in Isfahan, Iran. With over two decades of leadership in academia, research, and biotechnology entrepreneurship, she has significantly advanced cancer genomics, gene expression analysis, and personalized medicine. Her research spans diverse areas including breast cancer, cardiovascular disease, multiple sclerosis, drug resistance, and athletic genomics. In 2023, she founded PreventiGene, a genetics startup focused on early cancer detection. Dr. Azadeh has served as Chair of the Board at Control Tavan Novin Pouya since 2006, and has also managed the COVID-19 department at Jey Medical Diagnosis Laboratory. An active educator, she has taught for 20 semesters at Azad University and leads national technical training programs in biotechnology. She has authored books on laboratory methods and cancer diagnostics, serves as an editor for medical journals, and regularly collaborates with academic and industry partners to promote scientific innovation. She is widely recognized for her expertise in advanced technologies such as CRISPR, RNA sequencing, and high-throughput data analysis, and has developed and supervised numerous genetic research initiatives. Her technical skills span PCR/qPCR, ELISA, Western blotting, microbiology, and cell culture. As of October 2025, Dr. Azadeh has authored 34 indexed publications, with 313 citations, and holds an h-index of 13 , reflecting her impactful contribution to life sciences and translational research.

Profiles: Scopus | Google Scholar | LinkedIn | ResearchGate

Featured Publications

1. Bagheri, F., Mesrian Tanha, H., Mojtabavi Naeini, M., Ghaedi, K., & Azadeh, M. (2016). Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3′-untranslated region of ErbB4. Molecular Medicine Reports, 13(5), 4494–4498. 
Cited by: 39

2. Ebrahimi Ghahnavieh, L., Tabatabaeian, H., Ebrahimi Ghahnavieh, Z., & others. (2020). Fluctuating expression of miR-584 in primary and high-grade gastric cancer. BMC Cancer, 20, 621. 
Cited by: 31

3. Noormohammad, M., Sadeghi, S., Tabatabaeian, H., Ghaedi, K., Talebi, A., & others. (2016). Upregulation of miR-222 in both Helicobacter pylori-infected and noninfected gastric cancer patients. Journal of Genetics, 95(4), 991–995. 
Cited by: 29

4. Fattahi Dolatabadi, N., Dehghani, A., Shahand, E., Yazdanshenas, M., & others. (2020). The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer. Human Cell, 33(4), 1229–1239.
Cited by: 28

5. Adami, B., Tabatabaeian, H., Ghaedi, K., Talebi, A., Azadeh, M., & Dehdashtian, E. (2019). miR-146a is deregulated in gastric cancer. Journal of Cancer Research and Therapeutics, 15(1), 108–114.
Cited by: 28